Literature DB >> 1572821

Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe.

E J Maher1, L Coia, G Duncan, P A Lawton.   

Abstract

Six-hundred and forty four radiation therapists from 21 European countries, Canada, and the USA responded to a questionnaire regarding the management of three cases of advanced cancer. The cases were a 64-year-old man with brain metastases from small cell carcinoma of the lung; a 64-year-old woman with bone metastases from carcinoma of the breast and a 59-year-old man with squamous cell carcinoma of the bronchus and mediastinal nodes. There was variation as to the perceived prognosis and appropriate aims of therapy, particularly for the case of squamous cell carcinoma of the bronchus. The total dose and number of fractions could be related to the perceived aims and expectations of treatment, for example, those aiming to extend life gave higher doses of radiotherapy and those aiming only to relieve symptoms gave lower. Similarly, those describing treatment as radical and estimating longer survival gave higher doses and more fractions than those treating palliatively. Variations in the role of the radiation oncologist in the management of advanced and metastatic cancer in the USA, Canada and Europe are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1572821     DOI: 10.1016/0360-3016(92)90568-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

Review 1.  Palliative radiotherapy for bone metastases from lung cancer: Evidence-based medicine?

Authors:  Alysa Fairchild
Journal:  World J Clin Oncol       Date:  2014-12-10

2.  A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea.

Authors:  Yoonsun Chung; Woong Sub Koom; Yong Chan Ahn; Hee-Chul Park; Hak Jae Kim; Sang Min Yoon; Sangjin Shin; Yoon Jae Lee
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-10       Impact factor: 4.553

Review 3.  Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Authors:  Rosemary Stevens; Fergus Macbeth; Elizabeth Toy; Bernadette Coles; Jason F Lester
Journal:  Cochrane Database Syst Rev       Date:  2015-01-14

4.  European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey.

Authors:  Nicolas Magné; Cyrus Chargari; René Olivier Mirimanoff; Pierre Olivier; Jean Philippe Vuillez; Michèle Tubiana-Hulin; Jean Jacques Body; Jean Léon Lagrange
Journal:  Support Care Cancer       Date:  2010-08-31       Impact factor: 3.603

5.  Contested cumulations: configurations of cancer treatments through the twentieth century.

Authors:  John V Pickstone
Journal:  Bull Hist Med       Date:  2007       Impact factor: 1.314

6.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

Review 7.  Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy.

Authors:  Nicole M E Bradley; Janice Husted; Michael Sai Lai Sey; Amna F Husain; Emily Sinclair; Kristin Harris; Edward Chow
Journal:  Support Care Cancer       Date:  2006-11-09       Impact factor: 3.359

8.  Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?

Authors:  E A Grunfeld; A J Ramirez; E J Maher; D Peach; T Young; I P Albery; M A Richards
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

9.  Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.

Authors:  W K Evans; B P Will; J M Berthelot; M C Wolfson
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

10.  Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.

Authors:  C G Koedoot; R J de Haan; A M Stiggelbout; P F M Stalmeier; A de Graeff; P J M Bakker; J C J M de Haes
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.